The Neuroprotection Market exhibits a clear geographic leadership structure, with North America, particularly the United States, retaining its position as the dominant regional player. This market supremacy is the result of a powerful combination of factors: unparalleled investment in biomedical research, the presence of the world's leading pharmaceutical and biotechnology hubs, and a high...